These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis. Zhou T; Xie Y; Hou X; Bai W; Li X; Liu Z; Man Q; Sun J; Fu D; Yan J; Zhang Z; Wang Y; Wang H; Jiang W; Gao S; Zhao T; Chang A; Wang X; Sun H; Zhang X; Yang S; Huang C; Hao J; Liu J J Exp Clin Cancer Res; 2023 May; 42(1):111. PubMed ID: 37143164 [TBL] [Abstract][Full Text] [Related]
6. Trefoil factor 1 suppresses stemness and enhances chemosensitivity of pancreatic cancer. Yamaguchi J; Kokuryo T; Yokoyama Y; Oishi S; Sunagawa M; Mizuno T; Onoe S; Watanabe N; Ogura A; Ebata T Cancer Med; 2024 Jun; 13(11):e7395. PubMed ID: 38872370 [TBL] [Abstract][Full Text] [Related]
7. Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition. Ioannou N; Seddon AM; Dalgleish A; Mackintosh D; Solca F; Modjtahedi H Int J Oncol; 2016 Mar; 48(3):908-18. PubMed ID: 26781210 [TBL] [Abstract][Full Text] [Related]
8. ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4. Zhou T; Liu J; Xie Y; Yuan S; Guo Y; Bai W; Zhao K; Jiang W; Wang H; Wang H; Zhao T; Huang C; Gao S; Wang X; Yang S; Hao J Gut; 2022 Feb; 71(2):357-371. PubMed ID: 33674341 [TBL] [Abstract][Full Text] [Related]
9. Optimization for the blockade of epidermal growth factor receptor signaling for therapy of human pancreatic carcinoma. Solorzano CC; Baker CH; Tsan R; Traxler P; Cohen P; Buchdunger E; Killion JJ; Fidler IJ Clin Cancer Res; 2001 Aug; 7(8):2563-72. PubMed ID: 11489840 [TBL] [Abstract][Full Text] [Related]
10. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice. Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028 [TBL] [Abstract][Full Text] [Related]
11. Phospho-Aspirin (MDC-22) inhibits pancreatic cancer growth in patient-derived tumor xenografts and KPC mice by targeting EGFR: Enhanced efficacy in combination with irinotecan. Rodriguez Lanzi C; Wei R; Luo D; Mackenzie GG Neoplasia; 2022 Feb; 24(2):133-144. PubMed ID: 34968866 [TBL] [Abstract][Full Text] [Related]
12. Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling. Zhang Z; Han H; Rong Y; Zhu K; Zhu Z; Tang Z; Xiong C; Tao J J Exp Clin Cancer Res; 2018 Nov; 37(1):291. PubMed ID: 30486896 [TBL] [Abstract][Full Text] [Related]